[S11] Frontiers of mid-size drug discovery research —chemical approach that accelerates mid-size drug discovery—

3:45 PM - 4:05 PM JST(6:45 AM - 7:05 AM UTC)

[S11-3] Design of anti-miR21 oligonucleotide composed of acyclic nucleic acid

○Yukiko Kamiya^1,2,3 (1. Lab. of Bioanal. Chem., Kobe Pharmaceutical Univ., 2. Grad. Sch. of Eng., Nagoya Univ., 3. Inst. for Mol. Sci.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.